CG Oncology, Inc. (CGON)
Biological Products, (No Diagnostic Substances)
Latest Price
$73.79
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
11.92
P/B Ratio
6.19
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 8.51M | $604.0M | 9.64% | +1.53M | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 6.62M | $470.0M | 7.49% | -103.5K | 2026-06-30 |
| Decheng Capital LLC | 6.37M | $452.0M | 7.22% | -- | 2026-06-30 |
| BlackRock, Inc. | 6.26M | $444.0M | 7.08% | +1.19M | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 5.32M | $378.0M | 6.03% | -46.5K | 2026-06-30 |
| FMR LLC | 4.16M | $295.0M | 4.71% | +396.6K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.81M | $270.0M | 4.31% | +152.0K | 2026-06-30 |
| TCG Crossover Management, LLC | 3.67M | $260.0M | 4.16% | -- | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.47M | $246.0M | 3.92% | +370.1K | 2026-06-30 |
| Caption Management, LLC | 3.46M | $245.0M | 3.92% | +700.0K | 2026-06-30 |